Remdesivir News and Research

RSS
Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Study reveals how SARS-CoV-2 hijacks lung cells to drive COVID-19 severity

Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

WHO experts update guidance on COVID-19 treatments

WHO experts update guidance on COVID-19 treatments

Omicron variant BA.2.86 spreads faster, but current antivirals hold the line

Omicron variant BA.2.86 spreads faster, but current antivirals hold the line

Virginia Tech researchers develop new drug design framework to fight COVID-19

Virginia Tech researchers develop new drug design framework to fight COVID-19

AI-powered patient triage platform predicts COVID-19 severity and length of hospitalization

AI-powered patient triage platform predicts COVID-19 severity and length of hospitalization

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Differences in immune responses to IL-6 inhibition therapy between male and female COVID-19 patients

Proxalutamide shows promise as potential COVID-19 treatment

Proxalutamide shows promise as potential COVID-19 treatment

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Potential of COVID-19 convalescent plasma for future monoclonal antibodies against severe SARS-CoV-2 inflammation

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

Intranasal inoculation study sheds light on nasal and systemic immune responses to SARS-CoV-2

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

Unveiling the key defender: PLSCR1 identified as a potent anti-SARS-CoV-2 factor in COVID-19 immunity

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Two anti-inflammatory drugs reduce deaths in severe COVID-19 patients

Prior exposure to air pollutants and black carbon load predicts outcomes in hospitalized COVID-19 patients

Prior exposure to air pollutants and black carbon load predicts outcomes in hospitalized COVID-19 patients

Molecular insights into long COVID: serum proteome reveals dominant signaling pathways

Molecular insights into long COVID: serum proteome reveals dominant signaling pathways

Using heart and lung stem cells to better understand how COVID-19 impacts different organs

Using heart and lung stem cells to better understand how COVID-19 impacts different organs

When COVID meets Candida: exploring the alarming surge of C. auris in Israel

When COVID meets Candida: exploring the alarming surge of C. auris in Israel

Common diabetes drug prevents the development of long COVID, study finds

Common diabetes drug prevents the development of long COVID, study finds

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

Nanoparticles take aim at COVID-19 with lysosome-targeted delivery

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.